Medical Cannabis for Migraine & Cluster Headaches in the UK 2026 – Follow-Up & Deeper Insights
This follow-up article builds on the initial overview of medical cannabis for migraine and cluster headaches. It dives deeper into […]
This follow-up article builds on the initial overview of medical cannabis for migraine and cluster headaches. It dives deeper into […]
Workplace drug testing is common in the UK, particularly in safety-critical roles like driving, construction, or healthcare. With more patients
Endometriosis affects around 1 in 10 women and people with uteruses in the UK, causing severe pelvic pain, painful periods,
Migraine and cluster headaches affect millions in the UK, with migraine alone impacting ~1 in 7 adults. Standard treatments (triptans,
Bipolar disorder (formerly manic depression) involves extreme mood swings from manic/hypomanic highs to depressive lows. It affects around 1–2% of
Depression affects around 1 in 6 adults in the UK at some point, with symptoms including low mood, loss of
Post-Traumatic Stress Disorder (PTSD) affects around 4% of UK adults at some point, with symptoms including flashbacks, nightmares, hypervigilance, avoidance,
In 2025, the UK has over 40 private clinics prescribing CBPMs (cannabis-based products for medicinal use). The vast majority of
Attention Deficit Hyperactivity Disorder (ADHD) affects around 3–5% of UK adults and children, with symptoms including inattention, hyperactivity, and impulsivity.
Medical Cannabis and Driving Laws in the UK 2025 – What You Need to Know Medical cannabis (CBPMs) can cause